The US Food and Drug Administration said Friday it had told Johnson & Johnson that millions of doses of its COVID-19 vaccine produced at a troubled plant can’t be used because of possible contamination issues, AFP reported.
In a statement, the FDA said “several” batches of vaccine manufactured at the Emergent BioSolutions facility in Baltimore are not suitable for use. Each batch is known to correspond to several million doses.
(Arutz Sheva’s North American desk is keeping you updated until the start of Shabbat in New York. The time posted automatically on all Arutz Sheva articles, however, is Israeli time.)